Physician profile
Karim J Halazun
NPI 1326208976
$27,965.16
in general payments reported to CMS, 2019-2025
12 companies · $21K in 2025
The $21K reported for 2025 was more than what 95% of Transplant Surgery providers received nationally (typical 2025 total: $423).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $203 · 2020: $99.15 · 2023: $56.69 · 2024: $6,380 · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14K · Travel and Lodging: $8,516 · Food and Beverage: $3,630 · Consulting Fee: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14,017.50 |
| Travel and Lodging | $8,515.78 |
| Food and Beverage | $3,629.92 |
| Consulting Fee | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $20,420.05 | 2024-2025 | Therasphere Y90 Glass Microspheres 7.0 Gbq (US Commercial), Therasphere Y90 Glass Microspheres 10 Gbq |
| Transmedics, INC. | $6,187.41 | 2024-2025 | Organ Care System |
| Paragonix Technologies, INC. | $396.69 | 2024 | Liverguard, Sherpapak, Pancreaspak |
| Medtronic, INC. | $185.33 | 2024 | Signia, Aquamantys(Tm) |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $179.30 | 2025 | |
| Intuitive Surgical, INC. | $142.77 | 2019-2024 | |
| Intercept Pharmaceuticals, INC. | $123.33 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $110.79 | 2024 | Imfinzi |
| Kci USA, INC. | $84.20 | 2020 | |
| Olympus America INC. | $63.65 | 2019 | |
| Genentech USA, INC. | $56.69 | 2023 | Tecentriq |
| Tactile Systems Technology INC | $14.95 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karim Halazun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.